The Urinary Incontinence Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for urinary incontinence has seen robust growth in recent years. The market is expected to expand from $12.52 billion in 2024 to $13.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.8%.
The 2029 market projections for the Global Urinary Incontinence Market report predict a market size of $17.39 billion with a Compound Annual Growth Rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Urinary Incontinence Market Report and Uncover Key Trends Now!The key drivers in the urinary incontinence market are:
• Rising prevalence of comorbidities and lifestyle-related factors
• Implementation of population health strategies
• Increase in healthcare spending
• Medical advancements and innovative technologies in the field
The urinary incontinence market covered in this report is segmented –
1) By Type: Urge Incontinence, Stress Incontinence, Overflow Incontinence, Functional Incontinence
2) By Treatment Type: Medication, Devices, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By Diagnosis: Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
The key trends in the urinary incontinence market are:
• The future market is being shaped by continual medical advancements.
• Increased adoption of innovative technologies and non-invasive treatment methods are emerging trends.
• The integration of digital health and mhealth into treatment and care represents an upcoming trend.
• An increased focus on innovative product designs and patient-centered care are important emerging trends.
Major companies in the urinary incontinence market are:
• Cardinal Health Inc.
• Johnson and Johnson
• Medtronic PLC
• Eli Lilly and Company
• Asahi Kasei Corporation
• Becton Dickinson and Company (C.R. Bard Inc.)
• Teva Pharmaceutical Industries Ltd.
• Berry Global Inc.
• Boston Scientific Corporation
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Domtar Corporation
• Cook Medical Inc.
• Aurobindo Pharma Ltd.
• Coloplast AIS
• Teleflex Incorporated
• Apotex Inc.
• Zydus Lifesciences Limited
• ConvaTec Group PLC
• Cook Group Inc.
• Torrent Pharmaceuticals Ltd.
• Alennbic Pharmaceuticals Limited
• Laborie Medical Technologies Corp.
• NeoTract Inc.
• Ethicon Inc.
• Promedon GmbH
• Caldera Medical Inc.
North America was the largest region in the urinary incontinence market in 2024